| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), a leading enterprise software and consulting services company based in Tokyo, announced its Artificial Intelligence (AI) Software Development Division ("AI Division") has engaged with Heart-Tech Health to implement AI capabilities into its Med-Tech platform.
Heart-Tech Health offers a suite of SaaS solutions designed to identify women's cardiovascular risks at an early stage. Its proprietary software, Adesso, offers a comprehensive risk assessment and personalized health and wellness programs aimed to enhancing healthcare accessibility for all women. Expanding upon the previous engagement with the Company's subsidiary, Sigmaways, HeartCore's AI Division will now develop the AI data base for specific applications and insights, in addition to implementing natural language learning applications to enhance user experience within the Adesso Heart Score™ platform.
"Scaling up our partnership with HeartCore is a crucial step in technologically advancing our Adesso platform," said Heart-Tech Health Founder and CEO Dr. Suzanne Steinbaum. "At the heart of Adesso lies a commitment to educating and empowering women about cardiovascular risks early on to combat this epidemic. Our software's workflow has undergone substantial improvement, coupled with invaluable leadership guidance since engaging with Sigmaways and their talented development team last year. By partnering with HeartCore's AI division, we aim to harness the potential capabilities of artificial intelligence to propel our platform's efficiency, reach, and accessibility to continue making impactful strides in women's cardiovascular health awareness and prevention."
HeartCore CEO Sumitaka Kanno Yamamoto added: "I am pleased to announce our second contract awarded to our newly established AI division. AI innovation pairs seamlessly into our broader suite of software solutions, and this contract serves as a prime example of the cross-selling opportunities with our clients across our software business. Our dedicated team continues to make headway, securing new opportunities in the U.S. markets as we actively execute our global expansion initiatives. We are committed to leveraging the full potential and capabilities of AI to propel companies like Heart-Tech Health to drive business success and foster positive societal impact."
Posted In: HTCR
